| Camai Community Health Center, Inc. | |
|
# 2 School Rd Naknek AK 99633-0211 | |
| (907) 246-6155 | |
| (907) 246-6155 |
| Full Name | Camai Community Health Center, Inc. |
|---|---|
| Speciality | Clinic/Center |
| Location | # 2 School Rd, Naknek, Alaska |
| Authorized Official Name and Position | Mary Swain (EXECUTIVE DIRECTOR/CEO) |
| Authorized Official Contact | 9072466155 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Camai Community Health Center, Inc. Po Box 211 Naknek AK 99633-0211 Ph: (907) 246-6155 | Camai Community Health Center, Inc. # 2 School Rd Naknek AK 99633-0211 Ph: (907) 246-6155 |
| NPI Number | 1679718019 |
|---|---|
| Provider Enumeration Date | 12/15/2008 |
| Last Update Date | 09/01/2020 |
| Medicare PECOS PAC ID | 3476690876 |
|---|---|
| Medicare Enrollment ID | O20091016000135 |
News Archive
Tumourigenesis is driven by genetic alterations and by changes in the epigenome, for instance by the addition of methyl groups to cytosine bases in the DNA. A deeper understanding of the interaction between the genetic and epigenetic mechanisms is critical for the selection of tumour biomarkers and for the future development of therapies. Human tumour specimens and cell lines however contain a plethora of genetic and epigenetic changes, which complicate data analysis.
A revised Medicaid sterilization policy that removes logistical barriers, including a mandatory 30-day waiting period, could potentially honor women's reproductive decisions, reduce the number of unintended pregnancies and save $215 million in public health costs each year, according to researchers at the University of Pittsburgh School of Medicine.
The U.S. Food and Drug Administration announced that it has approved a fifth vaccine for protection against the 2009 H1N1 influenza virus. The vaccine is manufactured by ID Biomedical Corp. of Quebec, Canada, owned by GlaxoSmithKline PLC.
While examining patterns of DNA modification in lung cancer, a team of international researchers has discovered what they say is a surprising new mechanism.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679718019 | NPI | - | NPPES |
News Archive
Tumourigenesis is driven by genetic alterations and by changes in the epigenome, for instance by the addition of methyl groups to cytosine bases in the DNA. A deeper understanding of the interaction between the genetic and epigenetic mechanisms is critical for the selection of tumour biomarkers and for the future development of therapies. Human tumour specimens and cell lines however contain a plethora of genetic and epigenetic changes, which complicate data analysis.
A revised Medicaid sterilization policy that removes logistical barriers, including a mandatory 30-day waiting period, could potentially honor women's reproductive decisions, reduce the number of unintended pregnancies and save $215 million in public health costs each year, according to researchers at the University of Pittsburgh School of Medicine.
The U.S. Food and Drug Administration announced that it has approved a fifth vaccine for protection against the 2009 H1N1 influenza virus. The vaccine is manufactured by ID Biomedical Corp. of Quebec, Canada, owned by GlaxoSmithKline PLC.
While examining patterns of DNA modification in lung cancer, a team of international researchers has discovered what they say is a surprising new mechanism.
› Verified 1 days ago
Camai Community Health Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2 School Road, Naknek, AK 99633 Phone: 907-246-6155 Fax: 907-246-6158 | |
Naknek Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 192 Main Street, Naknek, AK 99633 Phone: 907-246-4214 Fax: 907-842-9203 |